We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.22B
AUM Growth
-$970M
Cap. Flow
-$969M
Cap. Flow %
-22.94%
Top 10 Hldgs %
17.21%
Holding
1,976
New
447
Increased
357
Reduced
374
Closed
503

Top Buys

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$21.5M
2
AAPL icon
Apple
AAPL
+$19.6M
3
ESTA icon
Establishment Labs
ESTA
+$17M
4
SNY icon
Sanofi
SNY
+$13M
5
HUBS icon
HubSpot
HUBS
+$12.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$62.1M
2
FBTC icon
Fidelity Wise Origin Bitcoin Fund
FBTC
+$55.8M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$53.5M
4
EXAS
Exact Sciences
EXAS
+$22.8M
5
NVDA icon
NVIDIA
NVDA
+$21.4M

Sector Composition

Rank Sector Weight
1 Healthcare 14.12%
2 Technology 11.17%
3 Industrials 6.47%
4 Consumer Discretionary 6.13%
5 Financials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSR
26
DELISTED
Whitestone REIT
WSR
$16.7M 0.4%
1,253,133
+593,277
+90% +$7.29M
NVS icon
27
Novartis
NVS
$304B
$16.3M 0.39%
153,043
-122,931
-45% -$12.3M
AAPL icon
28
CALL
Apple
AAPL
$4.99T
$16M 0.38%
+76,200
New +$14.2M
NVDA icon
29
NVIDIA
NVDA
$4.77T
$15.1M 0.36%
122,339
-211,661
-63% -$21.4M
ELAN icon
30
Elanco Animal Health
ELAN
$12.7B
$15M 0.36%
1,039,716
+241,187
+30% +$3.85M
NFLX icon
31
Netflix
NFLX
$301B
$15M 0.36%
222,150
+61,350
+38% +$3.83M
AVGO icon
32
Broadcom
AVGO
$1.81T
$14.6M 0.35%
91,080
+82,910
+1,015% +$11.6M
KBR icon
33
KBR
KBR
$4.74B
$14.5M 0.34%
226,751
+47,802
+27% +$3.09M
BDX icon
34
Becton Dickinson
BDX
$45.8B
$14.5M 0.34%
62,058
+17,716
+40% +$4.17M
SNY icon
35
Sanofi
SNY
$109B
$14.5M 0.34%
298,025
+269,045
+928% +$13M
SRPT icon
36
CALL
Sarepta Therapeutics
SRPT
$1.63B
$14.3M 0.34%
90,700
-241,800
-73% -$31.1M
TDS icon
37
Telephone and Data Systems
TDS
$3.87B
$14.3M 0.34%
691,185
+96,958
+16% +$1.75M
INDV icon
38
Indivior Pharmaceuticals
INDV
$4.85B
$14.3M 0.34%
912,050
-62,512
-6% -$1.13M
T icon
39
AT&T
T
$169B
$14.3M 0.34%
745,733
-59,274
-7% -$1.03M
ETN icon
40
Eaton
ETN
$150B
$14.2M 0.34%
45,394
+20,910
+85% +$6.75M
GMED icon
41
Globus Medical
GMED
$10.9B
$14M 0.33%
204,501
-46,889
-19% -$2.8M
ALNY icon
42
CALL
Alnylam Pharmaceuticals
ALNY
$38.5B
$13.5M 0.32%
55,400
+21,400
+63% +$3.38M
BCRX icon
43
BioCryst Pharmaceuticals
BCRX
$2.48B
$13.2M 0.31%
2,135,263
+1,672,929
+362% +$9.23M
VKTX icon
44
CALL
Viking Therapeutics
VKTX
$3.93B
$13.1M 0.31%
247,500
+232,600
+1,561% +$15.2M
APH icon
45
Amphenol
APH
$177B
$13.1M 0.31%
194,503
-188,183
-49% -$11.9M
WCN
46
Waste Connections
WCN
$42.7B
$13M 0.31%
73,854
-27,890
-27% -$4.66M
ANIK icon
47
Anika Therapeutics
ANIK
$202M
$12.7M 0.3%
501,950
-224
-0% -$5.8K
PENN icon
48
PENN Entertainment
PENN
$2.82B
$12.6M 0.3%
653,489
+617,827
+1,732% +$10.5M
BURL icon
49
Burlington
BURL
$23.3B
$12.6M 0.3%
52,507
+37,921
+260% +$7.8M
JNJ icon
50
Johnson & Johnson
JNJ
$643B
$12.5M 0.3%
85,599
+65,775
+332% +$9.78M
1
2
3 4 5

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Boothbay Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Boothbay Fund Management held 1,976 positions worth $4.22B, down 19% from $5.19B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management withdrew a net $969M in Q2 2024, closing 503 positions and reducing 374 holdings. Its most notable exit was Exact Sciences, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Boothbay Fund Management opened a new position in Sprott Physical Gold and Silver Trust worth $21.5M.

  • Boothbay Fund Management's largest Q2 2024 buy was Sprott Physical Gold and Silver Trust: 976,153 shares worth $21.5M.
  • Boothbay Fund Management added most to Apple in Q2 2024, an estimated $19.6M increase.
  • Boothbay Fund Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $62.1M.
  • Boothbay Fund Management fully exited Exact Sciences in Q2 2024, selling an estimated $22.8M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.22B portfolio in Q2 2024.
  • Boothbay Fund Management opened 447 new positions and closed 503 in Q2 2024.
  • Boothbay Fund Management's portfolio value fell 19% quarter-over-quarter to $4.22B.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.